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 Background: Rotational thromboelastometry (ROTEM®) is a point-of-care test for coagulation, enabling physicians to make a 
swift decision. The aim of this investigation was to establish reference intervals of thromboelastometric eval-
uation for coagulation in pediatric patients with congenital heart diseases (CHD).
 Material/Methods: As baseline data, 3 assays of ROTEM® (INTEM, EXTEM, and FIBTEM) were measured after anesthesia induc-
tion. ROTEM® parameters were clotting time (CT), amplitude at 10 min (A10), clot formation time (CFT), a an-
gle, maximal clot firmness (MCF), clot lysis index at 60 min (LI60), and maximal clot elasticity (MCE). As age is 
a well-known factor for maturation, age groups were determined as follows; 1) <1 month, 2) 1–3 months, 3) 
4–12 months, 4) 1–3 years, 5) 4–6 years, 6) 7–12 years, and 7) 13–16 years. Reference limits representing 95% 
of distribution of ROTEM® parameters and 90% confidence intervals of upper and lower reference limits were 
calculated.
 Results: The data of 413 patients were analyzed. Although INTEM CT was prolonged, significantly shorter CT and CFT, 
steeper a, and greater A10, MCF, and MCE were shown in patients age <3 months compared to older children.
 Conclusions: Reference intervals of thromboelastometric evaluation for coagulation from pediatric patients with CHD were 
shown to have similar pattern to those obtained from healthy pediatric patients. Pediatric patients with CHD, 
even with cyanosis, were demonstrated to have functionally intact coagulation profile before surgery.
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Background
Blood viscoelastic measurements, including thromboelastog-
raphy (TEG®) and rotational thromboelastometry (ROTEM®), 
are now known to provide a coagulation profile of critically ill 
patients with rapid visual evaluation of whole blood coagula-
tion, ranging from clot formation to lysis of the clot [1–3]. A 
critical care team employs a point-of-care test (POCT) for blood 
coagulation to make a swift decision at the bedside, and ulti-
mately to improve patient outcomes. Medical decision mak-
ing with a test or measurement is a process to compare the 
result of a patient with reference intervals. During cardiac sur-
gery, massive bleeding leads to transfusion, which makes ear-
ly detection of coagulopathy a critical step to reduce patient 
morbidity and mortality.
The ROTEM® machine (ROTEM®, TEM International, Munich, 
Germany) has been available in the operating room desig-
nated for congenital heart disease (CHD) surgery since 2009 
in our institution. At first, it was mainly utilized for investiga-
tional purposes, and was adopted as a routine measurement 
of blood coagulation in pediatric patients undergoing surgi-
cal intervention for CHD approximately 2 to 3 years later. Test 
results of a pediatric patient had been evaluated using refer-
ence intervals embedded in the ROTEM® machine. Those ref-
erence intervals were, however, made from measurements in 
the adult population [4]. Furthermore, to the best of our knowl-
edge, investigations to establish reference intervals of ROTEM® 
measurement in pediatric patients with CHD are rare. Previous 
investigations were done in healthy pediatric populations [5] 
and in a small number of pediatric patients with complex CHD 
or extreme age [6–8]. The aim of this retrospective investiga-
tion was to establish reference intervals of ROTEM® evaluation 
for coagulation in pediatric patients with CHD.
Material and Methods
The local ethics committee agreed to waive the requirement of 
informed consent from patients or the next of kin for this ret-
rospective investigation because the ROTEM® measurements 
were done as a routine procedure. Patients who had under-
gone surgical interventions for CHD under general anesthesia 
between October 2010 and May 2016 in a tertiary university 
hospital were recruited for analysis. Exclusion criteria were: age 
older than 16 years, inability to find baseline data of ROTEM® 
measurements, operations done out-of-hours or outside the 
operating room, and administration of blood products or any 
drug or fluid known to affect blood coagulation, such as colloid 
solution, given within a month before surgery. However, pros-
taglandin E1 for ductal patency was an exception because it 
could be vital for oxygenation for patients with ductal depen-
dency. As age is a well-known factor for functional maturation 
in pediatric patients, age groups were determined as follows 
in the light of previous investigations [5,9]: <1 month (neo-
nate), 1–3 months (early infant), 4–12 months (late infant), 1–3 
years (toddler), 4–6 years (preschool), 7–12 years (school), and 
13–16 years (adolescent). Preoperative data to be retrieved 
from electronic medical record system were demographic de-
tails, such as age, sex, height, body weight, and preoperative 
diagnosis, including cyanotic or acyanotic congenital heart dis-
ease. For baseline evaluation of blood cell count and coagula-
tion, the latest preoperative results of complete blood count 
and plasmatic coagulation tests, including hemoglobin (Hb), 
hematocrit (Hct), platelet count, functional fibrinogen level de-
termined by Clauss method, prothrombin time (PT), and acti-
vated partial thromboplastin time (aPTT), were also retrieved.
Anesthetic management
The patients were lightly sedated with IV ketamine <1.0 mg/kg 
or midazolam 0.5–1.0 mg as appropriate with patient age and 
body weight when arrived in the holding area of the operat-
ing room. The patient’s trachea was intubated after further se-
dation with additional bolus dose of IV ketamine or midazol-
am and muscle relaxation with IV vecuronium 0.4–0.5 mg/kg. 
Once mechanical ventilation was set up to obtain an end-tidal 
CO2 of 35-40 mmHg, anesthesia was maintained with sevoflu-
rane in O2/air with FiO2 of 0.6 and continuous infusion of suf-
entanil 0.1–0.3 µg/kg/hr. Central venous and femoral arterial 
catheters were inserted. When all the anesthetic procedures 
were completed, blood sampling for ROTEM® measurements 
was drawn via a 20-G, single-lumen, femoral arterial catheter.
ROTEM® measurements
ROTEM® was measured as a routine procedure of blood coag-
ulation management for pediatric patients undergoing surgical 
intervention for CHD. To collect baseline data for subsequent 
comparison, the first ROTEM® was measured after the induc-
tion of anesthesia, but before the surgery was initiated. A total 
of 1.5–2.0 ml blood was sampled after discarding a sufficient 
volume of blood to prevent contamination with heparin-con-
taining fluid. Drawn blood was immediately transferred to a ci-
trate-coagulated vacuum tube (Vacutainer®, BD, Franklin Lakes, 
NJ), and inserted into the designated hole in the ROTEM® ma-
chine for warming. Measurement was initiated within 15 min 
after blood sampling. Three assays of ROTEM®, which evaluate 
contact-activated, tissue factor-activated and fibrinogen polym-
erization pathways (INTEM, EXTEM, and FIBTEM, respectively) 
were done in the same ROTEM® machine. ROTEM® was mea-
sured at least for 60 min by an anesthesiologist with substan-
tial experience in ROTEM® measurement. Each assay of ROTEM® 
was measured with 300 µl of whole blood, which was warmed 
to 37°C before initiation of measurement. Warmed blood and 
assay-specific reagents were poured into a cup fixed in the cup 
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holder, using an automatic pipette system. Reagents required 
to activate each coagulation pathway were: 1) star-TEM with 
calcium chloride for both INTEM and EXTEM, 2) in-TEM: con-
tact activator comprised of partial thromboplastin phospholipid 
for INTEM, 3) ex-TEM: tissue factor containing thromboplastin 
for EXTEM, and 4) fib-TEM: platelet inhibitor (cytochalasin D) 
and calcium chloride for FIBTEM (TEM International, Munich, 
Germany). Once measurements were initiated, the results were 
displayed on the screen, and ultimately recorded and stored in 
the integrated computer of the ROTEM® machine. The parame-
ters of ROTEM® measurement to be retrieved to establish refer-
ence intervals were: clotting time (CT, time to initial appearance 
of clot, in seconds); amplitude at 10 min after initial appear-
ance of clot (A10); clot formation time (CFT, time from the first 
appearance of clot to an amplitude of 20 mm, in seconds); al-
pha angle (a, an angle between horizontal axis of time and tan-
gent to main body of trace from a time point of CT, in degrees); 
maximal clot firmness (MCF, the widest amplitude of main body 
of trace, in millimeters), clot lysis index at 60 min (LI60, a ratio 
of amplitude at 60 min after CT to MCF, as percentage); and 
maximal clot elasticity (MCE, calculated value from a formu-
la of 100×MCF/(100-MCF)) (Figure 1). For FIBTEM, parameters 
such as A10, MCF, and MCE, which evaluate clot strength, were 
only retrieved for analysis, because other parameters, includ-
ing CT, CFT, a, and LI60, are usually not used for evaluation of 
fibrin polymerization [4]. Data of ROTEM® measurements were 
retrieved as a text file (*.txt) and then tabulated into a work-
sheet using MICROSOFT® EXCEL® 2016 (MICROSOFT, Redmond, 
WA). Calibration of the ROTEM® machine was performed regu-
larly based on instructions from the manufacturer.
Statistical methods
The primary endpoint of this retrospective investigation was 
to establish reference intervals of previously described param-
eters of ROTEM® measurement in pediatric patients with CHD. 
Reference intervals were calculated as lower and upper ref-
erence limits with 2.5th and 97.5th percentiles of distribution 
of ROTEM® measurement results, as recommended by CLSI 
guidelines [10]. Because the number of patients in each age 
group was not expected to reach 120, which is a recommend-
ed number of reference individuals by CLSI guidelines, the ro-
bust method, as suggested by Horn and Pesce [11], was used 
to calculate reference limits and 90% confidence interval of 
each reference limit. The secondary endpoint was to compare 
the ROTEM® measurement results to find a possible difference 
1) between age groups and 2) between patients with acyanotic 
and cyanotic CHD. For comparison between age groups, data 
are presented as mean (SD) or median (interquartile range) 
and ANOVA or Kruskal-Wallis test were used, respectively, as 
indicated by results of the normality test. Multiple compari-
sons with Tuckey’s method were used as a post hoc test. For 
comparison between cyanotic and acyanotic patients, the t 
test or Wilcox signed rank sum test was done, as appropri-
ate, for normality testing. For testing normality of distribution, 
the Shapiro-Wilk test was used. Statistical analysis, including 
calculations of reference limits and confidence intervals, was 
performed with R studio (Ver. 0.99.902, RStudio Team (2015). 
RStudio: Integrated Development for R. RStudio, Inc., Boston, 
MA, URL. http://www.rstudio.com/) and R version 3.3.0 (R Core 
Team (2016). R: A language and environment for statistical com-
puting. R Foundation for Statistical Computing, Vienna, Austria. 
URL https://www.R-project.org/) with packages named “ref-
erenceIntervals” (Daniel Finnegan (2014). referenceIntervals: 
Reference Intervals. R package version 1.1.1. https://CRAN.R-
project.org/package=referenceIntervals), and nparcomp [12].
Results
The data of 1494 patients undergoing surgical interventions 
for CHD were retrieved. The data of 413 patients were ana-
lyzed after the exclusion of patients older than 16 years of age, 
those undergoing surgery out-of-hours or outside the oper-
ating room, those without available baseline data of ROTEM® 
measurements, those given blood products or any drug or flu-
id known to affect coagulation, and/or those undergoing re-
peated operations in which the latest operation was performed 
while the patient was still in the same age group. Details are 
depicted in Figure 2.
Patient characteristics are presented in Table 1. Sex ratio was 
similar between age groups (P=0.963). With advancing age, 
height, body weight, and body surface area were elevated 
(p<0.001). There was a difference in the number of children 
with cyanosis among age groups (P<0.01). Younger children 
were more likely to have cyanosis compared to older children.
Figure 1.  Rotational thromboelastometry (ROTEM®) parameters. 
CT – clotting time, CFT – clot formation time, 
A10 – amplitude at 10 min after CT, a – alpha angle, 
MCF – maximal clot firmness, LI60 – clot lysis index at 
60 min.
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Figure 2.  Flow chart representing the process of 
patient recruitment and selection.1494
Patients undergoing surgical
intervention for congenital heart diseases
944
Patients undergoing
surgical intervention in the OR
183
Patients undergoing surgical intervention
 out-of-hour or outside the OR
448
Patients whose baseline data of
ROTEM® measurements retrieved
496
Patients whose baseline data of ROTEM® 
measurements not found
30
Patients given blood product or drug
or fluid know to affect coagulation
within 1 month before surgery
5
Patients undergoing repeated
operations fallen into same age group
418
Patients who were lastly recruited
413
Patients finally
included in the analysis
1127
Patients <16 years of age
367
Patients 16 years of age
Neonate
(n=119)
Early infant
(n=76)
Late infant
(n=87)
Toddler
(n=55)
Preschool
(n=37)
School
(n=32)
Adolescent
(n=7)
p
Age
15.9±7.1
day
54.8±16.5
day
5.7±2.0
month
1.8±0.6
year
4.3±0.8
year
8.4±1.7
year
13.6±0.6
year
Sex 0.093
 Male  58 (48.7%)  37 (48.7%)  39 (44.8%)  25 (45.5%)  17 (45.9%)  16 (50.0%)  2 (28.6%)
 Female  61 (51.3%)  39 (51.3%)  48 (55.2%)  30 (54.5%)  20 (54.1%)  16 (50.0%)  5 (71.4%)
Height (cm)  49.0±4.5  54.0±5.1  62.3±6.7  82.4±7.8  100.5±8.4  127.5±10.8  156.5±8.9
Bodyweight (kg)  3.3±0.6  4.3±0.9  6.1±1.4  10.1±1.9  15.0±3.4  25.3±7.3  39.4±9.8
BSA (m2)  0.20±0.03  0.24±0.04  0.31±0.05  0.50±0.07  0.64±0.10  0.95±0.17  1.33±0.19
Cyanosis  15 (12.6%)  11 (14.7%)  15 (17.2%)  10 (18.2%)  15 (40.5%)  2 (6.2%)  1 (14.3%) <0.01
Table 1. Demographic data.
Data are number (%) or mean ±SD, as appropriate. BSA – body surface area.
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The preoperative results of complete blood count and plas-
matic coagulation tests are presented in Table 2. All hema-
tologic and plasmatic coagulation profiles except PT differed 
among age groups (all P<0.001). The Hb and Hct were signif-
icantly lower in early and late infants compared to other age 
groups (all p<0.05). Platelet count was significantly higher in 
early and late infants compared to that in children of older 
age groups (all p<0.05). The aPTT was significantly prolonged 
in neonates in comparison to other age groups (all p<0.05).
INTEM parameters were significantly different among all age 
group (all p<0.001 except LI60, in which p=0.014). Compared to 
those in late infant, toddler, preschool, and school age groups, 
CT was significantly prolonged, CFT was significantly shorter, 
and a was steeper in neonates and early infants (all p<0.05). 
Compared to all other age groups, A10, MCF, and MCE were 
significantly greater in neonates and early infants (all p<0.05) 
(Table 3). With LI60, no between-group difference was found 
with post hoc analysis. Apart from INTEM results, CT in EXTEM 
was significantly shorter in neonates and early infants compared 
to all other age groups. Other parameters showed a similar 
pattern to INTEM results: significantly shorter CFT and steep-
er a, and greater A10, MCF and MCE in neonates and early in-
fants compared to all other age groups (Table 4). For FIBTEM 
parameters, A10, MCF, and MCE were significantly greater in 
neonates and infants compared to those in late infant, tod-
dler, and preschool age groups (Table 5).
The results of ROTEM® measurements were classified on the 
basis of preoperative diagnosis of cyanotic and acyanotic CHD 
(Table 6). Although prolongation of CT in INTEM in cyanotic pa-
tients was not statistically significant compared to acyanotic 
patients, ROTEM® parameters of INTEM and EXTEM assays in 
cyanotic patients were shown to have significantly prolonged 
CT and CFT, and significantly reduced a, A10, MCF, and MCE. 
Clot lysis index was significantly different between cyanotic 
and acyanotic patients only in INTEM assay. FIBTEM parame-
ters of A10, MCF, and MCE were significantly lower in cyanot-
ic patients compared to that in acyanotic patients.
Reference limits representing 95% of distribution of ROTEM® 
parameters and 90% confidence intervals of upper and lower 
reference limits are presented in Tables 7–9, in which refer-
ence intervals obtained from otherwise healthy pediatric pa-
tients are also presented for comparison [5].
Neonate
(N=119)
Early infant
(N=76)
Late infant
(N=87)
Toddler
(N=55)
Preschool
(N=37)
School
(N=32)
Adolescent
(N=7)
p
Hb
(g/dL)
12.9 
[11.2; 14.4]
11.1* 
[10.2; 11.8]
11.4* 
[10.8; 12.6]
12.9†,‡ 
[11.9; 13.9]
13.7*,†,‡ 
[12.8; 16.1]
12.9†,‡ 
[12.2; 13.9]
14.5*,†,‡,§,@ 
[13.9; 15.3]
<0.001
Hct 
(%)
38.5 
[33.2; 43.0]
32.5* 
[29.8; 36.0]
34.1* 
[31.8; 37.5]
37.3†,‡ 
[35.5; 39.8]
39.8†,‡ 
[36.5; 49.8]
37.9†,‡ 
[35.9; 40.4]
42.0*,†,‡,§, @ 
[41.5; 44.5]
<0.001
Platelet
(×103/µl)
404.0 
[279.5; 481.5]
444.0 
[337.5; 534.5]
387.0 
[309.5; 451.0]
320.0†,‡ 
[261.5; 375.5]
307.0*,†,‡ 
[266.0; 358.0]
255.5*,†, ‡,§,# 
[232.0; 276.0]
222.0*,†, ‡ 
[207.0; 305.0]
<0.001
Fibrinogen
(mg/dL)
217.0 
[175.0; 263.0]
214.0 
[182.0; 248.0]
206.0 
[170.5; 244.5]
244.0*,†, ‡ 
[222.5; 284.5]
252.0*,†, ‡ 
[222.0; 292.0]
247.0‡ 
[216.0; 286.0]
227.0 
[184.0; 256.0]
<0.001
aPTT 
(sec)
44.5 
[39.5; 51.2]
38.1* 
[32.7; 41.2]
34.8* 
[31.7; 37.9]
33.6* 
[31.5; 37.2]
35.0* 
[33.1; 36.8]
34.9* 
[33.1; 36.9]
34.7* 
[34.0; 39.1]
<0.001
PT 
(sec)
11.9 
[10.9; 13.9]
11.5 
[10.9; 12.1]
11.7 
[11.0; 12.6]
11.5 
[10.9; 12.0]
12.1 
[11.3; 12.6]
12.4§ 
[11.6; 13.6]
11.4 
[11.0; 11.8]
0.008
ACT 
initial
143.0 
[129.0; 153.5]
144.0 
[132.5; 148.5]
132.0*,† 
[121.0; 143.0]
132.0* 
[123.0; 136.0]
133.0 
[127.0; 142.0]
140.0 
[131.0; 150.0]
150.0 
[140.5; 150.5]
<0.001
Table 2. Hematologic and plasmatic coagulation parameters classified with age groups.
Data are median [interquartile range]. Hb – hemoglobin, Hct – hematocrit, PT – prothrombin time; aPTT – activated partial 
thromboplastin time. * p<0.05, compared to Neonate; † p<0.05, compared to Early Infant; ‡ p<0.05, compared to Late Infant; § p<0.05, 
compared to Toddler; @ p<0.05, compared to School; # p<0.05, compared to Preschool.
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Neonate
(N=119)
Early infant
(N=76)
Late infant
(N=87)
Toddler
(N=55)
Preschool
(N=37)
School
(N=32)
Adolescent
(N=7)
p
CT
236.5 
[198.0; 297.0]
238.0 
[201.5; 282.0]
221.0*,† 
[177.0; 301.0]
205.0*,† 
[170.5; 242.5]
199.0* 
[169.0; 254.0]
195.0*,† 
[166.5; 229.0]
173.0*,† 
[150.0; 202.0]
<0.001
A10
63.0 
[59.0; 67.0]
63.0 
[58.0; 65.0]
56.0‡,§ 
[52.0; 62.0]
54.0‡,§ 
[50.0; 57.5]
53.0‡,§ 
[50.0; 56.0]
53.0‡,§ 
[49.0; 57.0]
49.0‡,@ 
[48.0; 54.0]
<0.001
CFT
50.5 
[42.0; 68.0]
52.0 
[44.0; 67.0]
69.0‡,§ 
[53.5; 89.0]
79.0‡,§ 
[63.0; 94.5]
79.0‡,§ 
[65.0; 105.0]
86.5‡,§ 
[71.5; 105.0]
88.0# 
[66.5; 97.5]
<0.001
MCF
67.0 
[64.0; 71.0]
67.0 
[63.0; 69.0]
62.0‡,§ 
[58.0; 67.0]
59.0‡,§ 
[56.0; 64.0]
59.0‡,§ 
[57.0; 64.0]
60.0‡,§ 
[56.0; 65.0]
57.0@,# 
[54.5; 60.0]
<0.001
a 80.0 
[76.0; 82.0]
79.0 
[76.0; 81.0]
77.0‡,§ 
[72.0; 79.0]
74.5‡,§ 
[71.0; 77.0]
74.0‡,§ 
[70.0; 77.0]
73.0‡,§ 
[70.0; 76.0]
73.0* 
[71.0; 76.5]
<0.001
LI60
94.0 
[92.0; 96.0]
93.0 
[91.0; 95.0]
93.0 
[91.0; 94.5]
91.5 
[88.5; 95.0]
92.5 
[90.0; 95.5]
94.0 
[89.5; 96.0]
92.0 
[90.0; 93.0]
0.014
MCE
206.0 
[181.0; 245.0]
205.0 
[170.0; 224.5]
164.0‡,§ 
[136.5; 199.5]
144.0‡,§ 
[128.0; 176.0]
147.0‡,§ 
[131.0; 176.0]
149.5‡,§ 
[128.5; 185.0]
134.0†,# 
[120.0; 148.5]
<0.001
Table 3. INTEM parameters of ROTEM measurement classified with age groups.
Data are median [interquartile range]. CT – clotting time; A10 – amplitude at 10 minutes after CT; CFT – clot formation time; 
MCF – maximal clot firmness; a – alpha angle; LI60 – clot lysis index at 60 minute; MCE – maximal clot elasticity. * p<0.05, compared 
to Neonate; † p<0.05, compared to Early Infant; ‡ p<0.001, compared to Neonate; § p<0.001, compared to Early Infant; @ p<0.01; 
compared to Early Infant; # p<0.01, compared to Neonate.
Neonate
(N=119)
Early infant
(N=76)
Late infant
(N=87)
Toddler
(N=55)
Preschool
(N=37)
School
(N=32)
Adolescent
(N=7)
p
CT 
47.0 
[41.5; 54.0]
45.0 
[40.5; 52.0]
55.0*,† 
[49.0; 63.0]
58.0‡,§ 
[46.0; 65.0]
56.0*,† 
[52.0; 68.0]
57.0*,† 
[51.5; 65.0]
62.0@,§ 
[56.0; 64.0]
<0.001
A10 
63.0 
[58.5; 67.5]
63.0 
[59.0; 66.5]
56.0*,† 
[52.5; 61.5]
54.0*,† 
[47.5; 58.5]
56.0*,† 
[49.0; 59.0]
54.0*,† 
[48.0; 59.0]
48.0*,† 
[46.0; 54.0]
<0.001
CFT 
59.0 
[50.5; 70.0]
58.0 
[49.0; 69.5]
72.0*,† 
[60.0; 87.5]
86.0*,† 
[69.5; 117.5]
86.0*,† 
[68.0; 108.0]
86.5*,† 
[74.0; 113.5]
101.0*,† 
[75.0; 110.5]
<0.001
MCF 
68.0 
[63.5; 71.0]
67.0 
[63.0; 70.0]
63.0*,† 
[60.0; 66.0]
60.0*,† 
[56.0; 64.5]
63.0*,† 
[60.0; 66.0]
61.0*,§ 
[56.0; 66.5]
56.0*,† 
[54.5; 60.0]
<0.001
a 78.0 
[76.0; 80.0]
78.0 
[76.0; 80.0]
75.0*,† 
[72.0; 78.0]
73.0*,† 
[68.0; 76.0]
73.0*,† 
[69.0; 76.0]
72.0*,† 
[68.0; 75.0]
70.0*,† 
[68.5; 74.5]
<0.001
LI60 
92.0 
[89.0; 95.0]
90.0 
[86.0; 92.5]
91.0 
[88.0; 93.0]
91.0 
[88.5; 95.0]
91.5 
[89.0; 94.0]
94.0 
[92.0; 96.0]
92.0 
[90.0; 92.0]
0.038
MCE 
212.0 
[174.0; 248.0]
204.5 
[171.5; 234.0]
170.0*,† 
[149.5; 196.5]
153.0*,† 
[126.5; 181.5]
168.0*,† 
[147.0; 194.0]
154.5*,† 
[128.5; 196.5]
128.0*,† 
[118.0; 150.0]
<0.001
Table 4. EXTEM parameters of ROTEM measurement classified with age groups.
Data are median [interquartile range]. CT – clotting time; A10 – amplitude at 10 minutes after CT; CFT – clot formation time; 
MCF – maximal clot firmness; a – alpha angle; LI60 – clot lysis index at 60 minute; MCE – maximal clot elasticity. * p<0.001, compared 
to Neonate; † p<0.001, compared to Early Infant; ‡ p<0.01, compared to Neonate; § p<0.01, compared to Early Infant; @ p<0.05, 
compared to Neonate.
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Neonate
(N=119)
Early infant
(N=76)
Late infant
(N=87)
Toddler
(N=55)
Preschool
(N=37)
School
(N=32)
Adolescent
(N=7)
p
A10
18.0 
[14.0; 21.0]
16.0 
[13.0; 19.0]
13.0*,† 
[10.0; 17.0]
12.0*,‡ 
[9.0; 15.5]
12.0*,‡ 
[9.0; 14.0]
11.5§ 
[9.0; 17.0]
11.0 
[7.0; 14.0]
<0.001
MCF
19.0 
[15.0; 23.5]
17.0 
[14.0; 21.0]
14.0*,† 
[11.0; 19.0]
13.0*,† 
[10.0; 17.5]
13.0*,† 
[11.0; 16.0]
13.5§ 
[10.0; 18.0]
12.0 
[8.0; 16.0]
<0.001
MCE
24.0 
[18.0; 30.5]
20.5 
[16.0; 26.0]
16.0*,† 
[12.0; 23.0]
15.0*,† 
[11.0; 21.0]
15.0*,† 
[12.0; 19.0]
15.5§ 
[11.5; 21.5]
13.0 
[8.0; 19.5]
<0.001
Table 5. FIBTEM parameters of ROTEM measurement classified with age groups.
Data are median [interquartile range]. A10 – amplitude at 10 minutes after CT; MCF – maximal clot firmness; MCE – maximal clot 
elasticity. * p<0.001; compared to Neonate; † p<0.05, compared to Early Infant; ‡ p<0.01, compared to Early Infant; § p<0.05, compared 
to Neonate.
Acyanosis (N=344) Cyanosis (N=69) p
INTEM CT  216.0 [181.0; 272.0]  227.0 [187.0; 295.0] 0.353
A10  59.0 [54.0; 64.0]  55.0 [47.0; 59.0] <0.001
CFT  62.0 [47.0; 81.0]  85.0 [55.0; 113.0] <0.001
MCF  65.0 [60.0; 68.0]  62.0 [55.0; 66.0] 0.001
a  77.0 [74.0; 80.0]  73.0 [69.0; 79.0] <0.001
LI60  93.0 [91.0; 95.0]  94.0 [92.0; 97.0] 0.008
MCE  182.0 [148.0; 216.0]  164.0 [124.0; 195.0] 0.001
EXTEM CT  51.0 [45.0; 59.0]  56.0 [48.0; 65.0] 0.014
A10  60.0 [54.0; 64.0]  56.0 [48.0; 60.0] <0.001
CFT  67.0 [56.0; 86.0]  77.0 [64.0; 111.0] <0.001
MCF  65.0 [61.0; 69.0]  62.0 [56.0; 67.0] <0.001
a  77.0 [73.0; 79.0]  74.0 [68.0; 77.0] <0.001
LI60  91.0 [88.0; 94.0]  92.0 [88.0; 96.0] 0.155
MCE  187.0 [158.0; 222.5]  160.0 [128.0; 200.0] <0.001
FIBTEM A10  15.0 [11.0; 19.0]  12.0 [10.0; 16.0] <0.001
MCF  16.0 [12.0; 21.0]  14.0 [11.0; 17.0] 0.007
MCE  19.0 [14.0; 27.0]  17.0 [12.0; 21.0] 0.009
Table 6. INTEM, EXTEM and FIBTEM parameters of ROTEM measurement classified with acyanotic and cyanotic diagnosis.
Data are median [interquartile range]. CT – clotting time; A10 – amplitude at 10 minutes after CT; CFT – clot formation time; 
MCF – maximal clot firmness; a – alpha angle; LI60 – clot lysis index at 60 minute; MCE – maximal clot elasticity.
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Neonate
(n=119)
Early infant
(n=76)
Late infant
(n=87)
Toddler
(n=55)
Preschool
(n=37)
School
(n=32)
Adolescent 
(n=7)
CT Ref intervals [5] 105–285 76–239 99–207 99–239 97–212 128–206
95% Ref Interval 94–383 102–374 44–402 104–307 73–327 91–304 91–304
90% CI
Lower 76–113 80–123 14–80 85–124 39–100 66–113 66–113
Upper 358 – 409 343–402 364–437 286–329 283–369 277–339 277–339
A10 Ref intervals [5] 50–72 47–70 45–67 45–68 45–66 48–67
95% Ref Interval 57–77 57–75 50–73 47–71 45–74 47–73 43–71
90% CI
Lower 56–58 55–59 48–52 45–49 38–51 43–50
Upper 76–79 73–76 71–75 69–74 68–81 69–77
CFT Ref intervals [5] 27–88 37–100 42–112 40–94 48–93 45–106
95% Ref Interval 22–120 31–91 29–158 43–145 35–195 48–162 36–191
90% CI
Lower 19–26 28–33 25–34 37–49 26–46 41–54
Upper 100–145 83–100 135–186 126–166 151–269 138–191
MCF Ref intervals [5] 54–71 52–73 56–72 53–73 53–69 54–71
95% Ref Interval 58–78 58–76 51–74 47–73 46–75 47–74 46–72
90% CI
Lower 56–59 57–60 48–53 44–49 40–53 44–51 41–49
Upper 77–80 75–78 71–76 70–76 68–81 70–77 65–83
a Ref intervals [5] 74–85 73–83 70–82 72–82 72–80 70–81
95% Ref Interval 67.5–92.3 68.1–90.1 63.0–90.0 58.7–90.4 59.7–87.4 63.8–81.9 63.1–85.1
90% CI
Lower 63.7–71.4 63.0–74.0 59.5–65.9 52.4–64.3 54.4–64.4 60.8–66.3 57.5–67.6
Upper 89.0–96.3 84.5–95.3 87.1–93.2 84.8–96.9 82.8–92.5 79.6–83.9 77.6–95.5
LI60 95% Ref Interval 89–100 87–99 87–100 83–100 84–101 84–104 84–99
90% CI
Lower 88–90 86–88 86–89 82–85 81–86 79–88
Upper 99–101 97–100 99–101 98–102 99–104 101–108
MCE 95% Ref Interval 110–310 122–280 89–244 67–221 83–224 69–239 76–234
90% CI
Lower 97–121 108–132 77–100 50–81 63–103 47–90 50–89
Upper 295–326 267–292 232–257 203–238 204–245 218–263 182–363
Table 7.  95% reference intervals and 90% confidence intervals of lower and upper reference limits of INTEM parameters of 
ROTEM measurement.
CI – confidence interval; CT – clotting time; A10 – amplitude at 10 minutes after CT; CFT – clot formation time; MCF – maximal clot 
firmness; a – alpha angle; LI60 – clot lysis index at 60 minute; MCE – maximal clot elasticity.
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Table 8.  95% reference intervals and 90% confidence intervals of lower and upper reference limits of EXTEM parameters of ROTEM 
measurement.
CI – confidence interval; CT – clotting time; A10 – amplitude at 10 minutes after CT; CFT – clot formation time; MCF – maximal clot 
firmness; a – alpha angle; LI60 – clot lysis index at 60 minute; MCE – maximal clot elasticity.
Neonate
(n=119)
Early Infant
(n=76)
Late Infant
(n=87)
Toddler
(n=55)
Preschool
(n=37)
School
(n=32)
Adolescent
(n=7)
CT Ref intervals [5] 38–65 37–77 37–73 46–97 43–74 44–91
95% Ref Interval 30–65 28–64 31–78 28–83 35–84 29–84 40–80
90% CI
Lower 28–32 25–31 27–36 24–34 29–39 20–37 16–47
Upper 62–67 60–68 74–83 77–89 79–90 75–94 74–105
A10 Ref intervals [5] 51-72 46–68 41–68 49–68 49–65 49–67
95% Ref Interval 58–80 57–74 52–72 48–73 52–75 48–74 45–69
90% CI
Lower 50–56 55–58 51–54 45–50 50–54 45–51 29–48
Upper 77–83 73–76 71–73 70–76 69–74 70–77 65–84
CFT Ref intervals [5] 30–105 44–146 46–139 41–109 49–114 53–115
95% Ref Interval 21–96 35–96 26–121 35–224 35–139 30–157 38–229
90% CI
Lower 13–28 32–37 13–40 25–45 25–52 14–43
Upper 88–104 87–107 106–135 174–309 126–155 142–178
MCF Ref intervals [5] 54–74 46–71 46–72 52–70 53–68 53–72
95% Ref Interval 55–81 58–77 53–74 48–74 53–73 48–74 45–69
90% CI
Lower 52–58 56–60 51–54 45–51 50–55 45–51
Upper 78–84 75–78 72–75 71–77 70–75 70–77
a Ref intervals [5] 69–84 68–82 64–81 69–82 67–80 67–80
95% Ref Interval 71.5–85.0 67.0–89.3 63.1–87.4 56.2–88.5 62.8–82.6 61.8–81.7 55.5–88.0
90% CI
Lower 70.5–72.6 61.4–72.7 57.8–68.9 50.2–60.5 59.6–65.2 59.1–64.3 34.9–64.8
Upper 84.0–86.1 83.5–94.6 81.6–92.2 84.0–94.6 79.5–84.3 79.4–83.9 84.6–106.0
LI60 Ref intervals [5] 71–94 71–95 77–94 74–93 70–97 76–94
95% Ref Interval 78–106 79–100 83–100 84–99 83–100 86–103 85–98
90% CI
Lower 73–83 77–82 81–85 82–85 82–89
Upper 102–111 99–102 98–101 98–101 100–106
MCE 95% Ref Interval 114–312 121–292 94–246 77–232 96–240 73–252 68–198
90% CI
Lower 101–126 108–133 83–105 62–93 80–112 53–94
Upper 299–325 277–306 234–259 216–248 222–257 231–277
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Discussion
Patients undergoing surgical interventions for CHD before 3 
months of age had a coagulation profile of faster initiation and 
propagation of clot formation and more enhanced clot strength 
when compared to older patients. On the other hand, patients 
with cyanotic CHD showed slower initiation and propagation 
of clot formation and weaker clot strength compared to pa-
tients with acyanotic diseases. Reference intervals obtained 
from pediatric patients undergoing surgical interventions for 
CHD had similar results and pattern to those obtained from 
otherwise healthy pediatric patients [5].
For a specific test or measurement, it is commonly recom-
mended that a laboratory or institute determine their own ref-
erence intervals from their own patient population [5,13,14]. 
Test results depend not only on pre-analytic factors, such as 
sampling technique and handling or storage of samples, but 
also on characteristics of the particular patient population. 
Therefore, this retrospective investigation was planned to ob-
tain reference intervals of thromboelastometric evaluation for 
coagulation from pediatric patients with CHD in our institu-
tion. ROTEM® measurement does have its own reference in-
tervals embedded in the ROTEM® machine and depicted as a 
“normal guideline”, which enables quick and intuitive inter-
pretation of ongoing measurement result. However, for pedi-
atric patients with CHD, such as in this study, this convenient, 
real-time interpretation could be inaccurate or misleading be-
cause the reference intervals were obtained from an otherwise 
healthy adult population.
There have been few investigations that compared ROTEM® 
parameters of pediatric patients with CHD, mostly cyanotic, 
to those of otherwise healthy pediatric patients or pediatric 
patients with acyanotic CHD [6,7]. These investigations were, 
however, done in a limited number of patients and were de-
signed for comparison, not to obtain the reference intervals. 
The CLSI task force recommended that if the reference popula-
tion did not reach 120 individuals, which is the minimal num-
ber of reference individuals they recommend, a specific for-
mula has to be utilized to calculate reference intervals. One 
investigation calculated reference intervals of ROTEM® param-
eters from a large number of otherwise healthy pediatric pa-
tients undergoing non-cardiac/minor surgical procedures fol-
lowing CLSI guidelines on reference intervals [5]; when the 
reference intervals calculated in were compared to those cal-
culated from otherwise healthy pediatric patients, both refer-
ence intervals overlapped, but the reference intervals had a 
tendency to have broader ranges compared to that of other-
wise healthy pediatric patients. Furthermore, both reference 
intervals had a similar age-related pattern of longer INTEM CT 
but shorter EXTEM CT, shorter CFT and steeper a in INTEM and 
EXTEM, and greater A10 and MCF in INTEM, EXTEM, and FIBTEM 
in neonates and infants, compared to those in older children.
Table 9.  95% reference intervals and 90% confidence intervals of lower and upper reference limits of FIBTEM parameters of ROTEM 
measurement.
Neonate
(n=119)
Early infant
(n=76)
Late infant
(n=87)
Toddler
(n=55)
Preschool
(n=37)
School
(n=32)
Adolescent
(n=7)
A10 Ref intervals [5] 8–22 6–24 5–24 7–22 7–21 3–22
95% Ref Interval 10–35 9–30 6–30 7–28 6–28 4–36 3–42
90% CI
Lower 9–11 8–10 5–7 6–8 5–7 3–6 0.7–5
Upper 32–39 28–33 27–35 25–32 23–33 27–48 25–214
MCF Ref intervals [5] 8–23 7–25 6–24 7–23 7–22 8–24
95% Ref Interval 10–36 9–32 6–32 6–28 6–27 5–39 3–41
90% CI
Lower 9–11 8–10 5–7 5–7 5–7 4–6 1–6
Upper 33–40 29–36 28–36 24–33 21–32 30–50 25–209
MCE 95% Ref Interval 10–52 10–44 6–44 6–37 6–37 5–48 3–62
90% CI
Lower 1–12 9–11 5–7 5–8 4–7 4–6 1–6
Upper 47–59 39–50 36–54 31–46 28–47 35–65 34–479
CI – confidence interval; CT – clotting time; A10 – amplitude at 10 minutes after CT; CFT – clot formation time; MCF – maximal clot 
firmness; a – alpha angle; LI60 – clot lysis index at 60 minute; MCE – maximal clot elasticity.
3585
Indexed in: [Current Contents/Clinical Medicine] [SCI Expanded] [ISI Alerting System]  
[ISI Journals Master List] [Index Medicus/MEDLINE] [EMBASE/Excerpta Medica]  
[Chemical Abstracts/CAS] [Index Copernicus]
KimJ.Y. et al.: 
Thromboelastometry in children with CHD
© Med Sci Monit, 2016; 22: 3576-3587
CLINICAL RESEARCH
This work is licensed under Creative Common Attribution-
NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
For prolongation of INTEM CT, our data (>200 s) was longer 
than that of otherwise healthy pediatric patients (>170) [5], 
but shorter than that of pediatric patients with complex CHD, 
mostly cyanotic CHD (>250) [6]. The prolongation of INTEM CT 
could be attributed to cyanosis, because, although statistically 
not significant, patients with cyanotic CHD in this investiga-
tion were also shown to have prolonged INTEM CT compared 
to patients with acyanotic CHD. The EXTEM CT was shown to 
have a reversed direction against the INTEM CT, shorter than 
that in older children. This age-related discrepancy in rate of 
clot initiation between the contact-activated and tissue fac-
tor-activated coagulation pathways was not clearly defined 
because coagulation factor assays are not included in routine 
preoperative evaluation, but some of the difference in matu-
ration of respective coagulation activators could be attribut-
ed to such a discrepancy [5].
Blood cell count and plasmatic coagulation test parameters 
showed a similar age-related pattern to the results of an inves-
tigation by Oswald et al. [5]; red blood mass and fibrinogen lev-
el were elevated with advancing age, but platelets were higher 
in neonates and infants. The aPTT was prolonged in neonates 
and infants, but PT was not significantly different among the 
age groups. These findings are, however, within age-specific 
reference ranges of blood cell count and plasmatic coagulation 
tests in healthy pediatric patient population [15].
The age-related pattern of “hypercoagulability” in neonates 
and infants younger than 3 months of age have been previ-
ously demonstrated [5,6,16]. Although the plasmatic coagula-
tion test results of aPTT were prolonged and fibrinogen level 
was reduced in neonates and infants compared to older chil-
dren, functional profile of coagulation was not compromised. 
Most importantly, reference intervals calculated from pediat-
ric patients with CHD overlapped with the reference intervals 
calculated from adults [4]. Even the data from patients with 
cyanotic CHD, a group known to have a certain defect in co-
agulation [17], were within the reference intervals calculated 
from adults. Additionally, hyperfibrinolysis, which was report-
ed to be a primary mechanism for coagulation abnormality, 
especially in patients with cyanotic CHD [17], was not observed 
preoperatively in this investigation, even in patients with cya-
notic CHD. Therefore, patients with CHD, even those with cy-
anotic CHD, are not to be regarded as having “impaired” co-
agulation, but rather as having an exaggerated coagulation 
profile with greater variability.
There are several limitations in the present investigation. First, 
the number of patients was limited, especially for adolescents, 
so confidence intervals for several ROTEM parameters could 
not be calculated. To the best of our knowledge, our investi-
gation is the first to recruit more than 100 pediatric patients 
with CHD to obtain reference intervals of ROTEM parameters, 
but further study is needed for refined calculation, with more 
than 120 patients in each age group. Second, assays of coag-
ulation factors were not included in the routine preoperative 
evaluation. With such information, further data to explain re-
sults of this investigation, for example, the discrepancy between 
INTEM and EXTEM CTs, would have been possible. Lastly, al-
though the outliers were intrinsically removed within a pro-
cess of calculation of reference intervals, some moderate out-
liers would be included for final calculation, and it could be 
attributed to the broader ranges of reference intervals used in 
this investigation compared to those calculated prospectively.
Conclusions
The reference intervals of preoperative results of thromboelas-
tometric evaluation for blood coagulation from pediatric pa-
tients with CHD calculated in this investigation were shown 
to have a similar pattern to reference intervals obtained from 
otherwise healthy pediatric patients. Pediatric patients with 
CHD, even those with cyanotic CHD, were demonstrated to have 
functionally intact coagulation profile before surgery for CHD.
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